Olema Pharmaceuticals Inc expected to post a loss of 58 cents a share - Earnings Preview

Olema Pharmaceuticals

06/11/2024 14:21

* Olema Pharmaceuticals Inc  OLMA.OQ   OLMA.O  is expected
to show
no change in quarterly revenue when it reports  results on
November 8 (estimated) for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Olema Pharmaceuticals
Inc is
for a loss of 58 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Olema
Pharmaceuticals Inc is 29.50​, above​ its last closing price
of $12.06. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.55       -0.55      -0.54     Beat    2.6
 Jan. 1 0001   -0.55       -0.55      -0.56     Missed  -2.6
 Dec. 31 2023  -0.48       -0.48      -0.49     Missed  -1.9​
 Sep. 30 2023  -0.50       -0.51      -0.48     Beat    6.1
 ​​Jun.        -0.72       -0.73      -0.49     Beat    32.6
 30 2023                                                
 Mar. 31 2023  -0.71       -0.66      -0.70     Missed  -5.5​
 Dec. 31 2022  -0.62       -0.65      -0.65     Met     0.3
 Jan. 1 0001   -0.76       -0.77      -0.57     Beat    25.8
 This summary was machine generated November 6 at 14:20 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)